Guardant Health, Inc. is 4.5x more valuable than VERACYTE, INC. by market capitalization ($17.33 B vs $3.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCYT | GH |
|---|---|---|
| Market cap | $3.84 B | $17.33 B |
| US-listed rank | #1603 | #671 |
| Revenue (latest FY) | $517.14M | $982.02M |
| Net income (latest FY) | $66.40M | -$416.30M |
| Net margin | 12.8% | -42.4% |
| P/E (trailing FY) | 57.9 | - |
| SEC filings | 1,126 | 1,131 |
Guardant Health, Inc. is 4.5x more valuable than VERACYTE, INC. by market capitalization ($17.33 B vs $3.84 B).
In their latest fiscal years, VERACYTE, INC. reported $517.14M in revenue while Guardant Health, Inc. reported $982.02M.
Full pages: VERACYTE, INC. and Guardant Health, Inc., or browse the full rankings.